Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

Madhavan Nair

Madhavan Nair

Ph.D. Distinguished Professor and Founding Chair Department of Immunology Director,Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Associate Dean, Biomedical Research,
Florida International University
USA

Biography

Madhavan Nair, PhD received his PhD from Tata Memorial Cancer Center, Bombay University, India in Cancer Immunology and trained at Memorial Sloan Kettering Cancer Center, New York City. He then joined the faculty of the Department of Pediatrics at University of Michigan, Ann Arbor and subsequently worked at the Department of Medicine and Microbiology at SUNY, Buffalo, NY as a Tenured Professor and Director of Research in Allergy and Immunology. He is a certified Clinical Nutrition Specialist (CNS), Fellow of American College of Nutrition (FACN) and Fellow of American Academy of Allergy, Asthma and Immunology (FAAAI). Currently working as Distinguished Professor and Founding Chair, Dept. of Immunology, Director, Institute of Neuro-Immune Pharmacology and Center for Personalized NanoMedicine,HW College of Medicine, Associate Dean, Bio. Med. Res, Florida International University.

Research Interest

Nair and his colleagues discovered the suppressor factor in cancer serum (1978) and first reported that intravenous drug users manifest low natural killer cell activity (1986) and morphine induces apoptosis of normal lymphocytes (1997). In 1988, Dr Nair reported for the first time (PNAS) that HIV recombinant purified gene products possess significant biological activities. His original discovery that cocaine increases the sensitivity to HIV infection by increasing the HIV co-receptors and methamphetamine exacerbates the HIV replication in dendritic cells had a profound effect on the role of these drugs on HIV disease progression. His recent research mainly involves the role of different drugs of abuses such as alcohol, morphine, cocaine and methamphetamine on neuro-AIDS and therapeutic approach to control Neuro-AIDS by specific drug targeting to brain using nanotechnology(Nature.Com 2013). Nair is the first FIU researcher to earn a prestigious MERIT Award from the National Institutes of Health recognizing outstanding competence and productivity in research (2008-2018). Nair is also the recipient of University of Michigan Distinguished Research Scientist Award (1990), Exceptional Research Scholar Award from State University of New York (2005), Excellence in Faculty Scholarship Award from FIU (2008) and Presidential Leadership Operational Excellence Award from FIU in 2009, Recipient of FIU's Top Research Scholar Award 2010,Honorary Charter Member, Florida International University, National Academy of Inventors 2012; Best of Miami (Miami Today) May 2013;The Wybran Award,Society on NeuroImmune Pharmacology, 2014;FIU Research Recognition Award, 2014;Health Care Heroes Award: Greater Miami Chamber of Commerce Finalist (Results will be declared on May 19th 2015,) 2015. Nair has published more than 180 papers as first and/or senior author, mentored more than 50 undergraduate, graduate, postdoctoral fellows, high school and minority students, served in various committees, organized various national and international conferences, chaired number of scientific sessions and served in various NIH study sections committees as chair/ member since 1980. His research is currently supported with seven major NIH grants.